Alio launches calibration and validation (cava) study to expand alio platform's fda clearance beyond the vascular access for use in a broader range of patients

Broomfield, colo.--(business wire)--alio launches calibration and validation (cava) study. expands fda clearance beyond the vascular access for use in a broader range of patients.

CAVA Ratings Summary

CAVA Quant Ranking